Neoatricon (Dopamine Hydrochloride)

Dopamine Hydrochloride, the active ingredient in Neoatricon, is a catecholamine presented as an injectable solution for intravenous use. It is employed to support cardiovascular function in patients with low blood pressure, cardiogenic shock, or acute heart failure, acting to improve cardiac output and renal perfusion.

GNH USA supplies Neoatricon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assured distribution channels and regulatory compliance across EU and global markets, ensuring timely delivery and product integrity.

Neoatricon, a catecholamine vasopressor, is used in the management of cardiovascular conditions characterized by low perfusion or impaired cardiac output.

- Hypotension: Increases blood pressure by stimulating dopaminergic and β1‑adrenergic receptors, improving organ perfusion. - Cardiogenic shock: Enhances myocardial contractility and cardiac output, supporting circulation during acute pump failure. - Acute heart failure: Augments renal blood flow and reduces systemic vascular resistance at low doses, aiding decongestion and hemodynamic stability.

Dopamine infusion may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Nausea or vomiting: gastrointestinal discomfort. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Severe hypertension: dangerous rise in blood pressure. - Myocardial ischemia: reduced heart muscle blood flow. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation.

When using Neoatricon, clinicians should observe several precautionary measures to minimize risks.

- Monitor blood pressure: check continuously during infusion. - Observe cardiac rhythm: watch for arrhythmias. - Adjust dose based on response: titrate to target hemodynamics. - Use cautiously in pheochromocytoma: risk of hypertensive crisis. - Avoid in uncorrected tachyarrhythmias: may exacerbate condition. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Dopamine may interact with other medications, requiring careful assessment before co‑administration.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis. - β‑blockers: can blunt dopamine’s inotropic effect. - α‑adrenergic antagonists: may reduce vasoconstrictive response.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive hypotensive effect. - Diuretics: may enhance volume depletion. - Other vasopressors: risk of excessive vasoconstriction. - Anesthetic agents: may alter cardiovascular response.